The present invention relates to pyrazolotriazines according to formula (I)
##STR1##
and stereoisomers, isomers and salts thereof wherein R1-R5 are
selected from certain alkyl, aryl and heteroaryl species as defined in the specification
wherein all of the compounds are useful as CRF antagonists and are thus useful
in the treatment of neurological disorders as well as a multitude of other CRF
associated diseases or conditions.
